Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Clinical trial NCT02122809 · COMPLETED
Trial details
- NCT number
- NCT02122809
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.